Acquirer Profile
Lilly Acquisitions & Deals (2026)
biotechnology · Pharmaceuticals · Biotechnology
Deals tracked
4
Combined value
$10.4B
Primary sector
biotechnology
Active
2026
FireStrike tracks every Lilly acquisition, merger, and strategic investment in real time. This page covers 4 Lilly deals totaling $10.4B in disclosed deal value, spanning biotechnology, Pharmaceuticals, Biotechnology. Data covers 2026.
Lilly Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
LimmaTech Biologics Biotechnology | May 2026 | |
Ajax Therapeutics Pharmaceuticals | Apr 2026 | |
Curevo Vaccine Biotechnology | May 2026 | |
Engage Bio Biotechnology | May 2026 |
Lilly Acquisitions — FAQ
How many acquisitions has Lilly made?
Lilly has made 4 acquisitions and deals tracked on FireStrike, totaling $10.4B in combined deal value.
What sectors does Lilly acquire in?
Lilly primarily acquires in biotechnology, Pharmaceuticals, Biotechnology.
What is Lilly's most recent acquisition?
Lilly's most recent tracked acquisition is LimmaTech Biologics for $4B, announced May 2026.
Get every Lilly deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →